why choose us

First received: July 26, 2022

Clinical Trial: The Pharmacodynamics of Cannabinoid-Caffeine Combinations

Study Status: Completed

Recruit Status: RECRUITING

Condition: Behavioral Pharmacology of Cannabinoids

Study Type: INTERVENTIONAL


Official Title: A Double-Blind, Randomized, Placebo-Controlled, Within-Subject Crossover Study of the Effects of Combinations of Cannabinoids and Caffeine

Brief Summary: Cannabis and caffeine are two of the most commonly consumed psychoactive substances in the world, with many consumers reporting positive impacts on energy, alertness, and focus.Preliminary evidence has suggested that cannabidiol (CBD), the non-intoxicating cannabinoid found in cannabis, may mitigate the negative side effects of caffeine (e.g., feeling jittery) without impacting positive or desired effects.CBD also shows potential in reducing undesirable acute effects (e.g., anxiety) of delta-9-tetrahydrocannabinol…

Read more